Imagine a place where all specialty pharmacies and their partners gather together.  This year’s Asembia Specialty Pharmacy Summit conference, held April 29 – May 2 in Las Vegas, saw more than 6,000 attendees for three full days of networking…

According to the American Stroke Association, 80% of all strokes are preventable. Sadly, CDC statistics show that stroke kills approximately 140,000 Americans each year, accounting for 1 in 20 deaths. A stroke occurs every 40 seconds in the…

In this month’s 340Buzz, the battle over the 340B program continues, further delays on the ceiling price rule, Senate hearings and a new House bill, and HHS asks 340B stakeholders for feedback.

Customer success versus account management How do SaaS (software as a service) companies like Sentry Data Systems best align with customer needs? We embarked on the customer success journey three years ago and began attending the Pulse conference,…

With spring upon us and new life blooming everywhere, efforts to reform 340B, or overturn the CMS reimbursement cut ruling, remain in hibernation. New study proves value of 340B On March 12, health policy research firm L&M Policy Research…

The theme for the 2018 American College of Healthcare Executives (ACHE) Conference was change—big change is coming and leaders will need to be prepared to be part of it or face extinction. While conference attendees paved the streets of downtown…

While March Madness is upon us and we filled our brackets in hopes of getting close to the sweet 16—let alone the final four—Sentry began the month at the HIMSS 2018 Conference in Las Vegas, Nevada. Sentry had an engaging conference experience…

Sentry Data Systems recently hired Envision Health, a Detroit-based, clinically informed healthcare marketing and PR consulting firm, to conduct in-depth research interviews with hospital 340B program managers and leading independent 340B consulting firms to better understand their top 340B priorities.

The American Hospital Association and other hospitals and groups are still working to appeal the U.S. District Court for the District of Columbia’s December 29 decision to dismiss the AHA lawsuit that had been filed against CMS to prevent the 340B program reimbursement cuts from taking effect.